T. Rowe Price Associates’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-535,315
Closed -$2.46M 2634
2020
Q2
$2.46M Sell
535,315
-55,768
-9% -$256K ﹤0.01% 1492
2020
Q1
$1.96M Sell
591,083
-122,199
-17% -$404K ﹤0.01% 1500
2019
Q4
$4.36M Sell
713,282
-37,596
-5% -$230K ﹤0.01% 1418
2019
Q3
$3.13M Sell
750,878
-45,358
-6% -$189K ﹤0.01% 1455
2019
Q2
$10.4M Buy
796,236
+144,535
+22% +$1.9M ﹤0.01% 1307
2019
Q1
$6.2M Buy
651,701
+600
+0.1% +$5.71K ﹤0.01% 1378
2018
Q4
$2.01M Buy
+651,101
New +$2.01M ﹤0.01% 1557